Home Other Building Blocks 16338-48-0
16338-48-0,MFCD00002627
Catalog No.:AA001TZN

16338-48-0 | L-Allylglycine

Pack Size
Purity
Availability
Price(USD)
Quantity
  
250mg
98%
in stock  
$7.00   $5.00
- +
1g
98%
in stock  
$14.00   $10.00
- +
5g
98%
in stock  
$31.00   $22.00
- +
10g
98%
in stock  
$57.00   $40.00
- +
25g
98%
in stock  
$139.00   $97.00
- +
  • Technical Information
  • Properties
  • Upstream Synthesis Route
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Upstream Synthesis Route
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA001TZN
Chemical Name:
L-Allylglycine
CAS Number:
16338-48-0
Molecular Formula:
C5H9NO2
Molecular Weight:
115.1305
MDL Number:
MFCD00002627
SMILES:
N[C@H](C(=O)O)CC=C
Properties
Properties
 
BP:
231 °C at 760 mmHg  
Form:
Solid  
MP:
253-255 °C  
Refractive Index:
1.4538 (estimate)  
Solubility:
H2O: 100 mg/mL  
Storage:
Keep in dry area;Room Temperature;  

Computed Properties
 
Complexity:
101  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
1  
Heavy Atom Count:
8  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
2  
Rotatable Bond Count:
3  
XLogP3:
-2.3  

Upstream Synthesis Route

[1]JournaloftheAmericanChemicalSociety,1987,vol.109,#15,p.4649-4659

[1]JournaloftheAmericanChemicalSociety,1987,vol.109,#15,p.4649-4659

[1]JournaloftheAmericanChemicalSociety,1996,vol.118,#32,p.7449-7460

[1]JournalofOrganicChemistry,2000,vol.65,#22,p.7310-7322

[2]TetrahedronAsymmetry,1998,vol.9,#22,p.3935-3938

[3]TetrahedronAsymmetry,1998,vol.9,#7,p.1125-1129

[1]TetrahedronLetters,1994,vol.35,#1,p.29-32

[2]JournaloftheAmericanChemicalSociety,1989,vol.111,#16,p.6354-6364

[3]JournalofBiologicalChemistry,1955,vol.213,p.39,40

Downstream Synthesis Route

[1]EuropeanJournalofOrganicChemistry,2008,p.3107-3112

[2]OrganicLetters,2019,vol.21,p.8473-8478

[3]Patent:WO2020/51532,2020,A2.Locationinpatent:Page/Pagecolumn453;480;481;482

[4]JournaloftheChemicalSociety,1962,p.3963-3968

[5]Heterocycles,1981,vol.15,p.819-822

[6]JournalofMedicinalChemistry,1994,vol.37,p.2841-2845

[7]JournaloftheAmericanChemicalSociety,1996,vol.118,p.7449-7460

[1]Patent:WO2008/50096,2008,A1.Locationinpatent:Page/Pagecolumn50

[2]Patent:WO2004/80983,2004,A1.Locationinpatent:Page42-44

[3]JournaloftheAmericanChemicalSociety,2000,vol.122,p.8890-8897

[4]Tetrahedron,2001,vol.57,p.6567-6578

[5]Patent:US2002/156018,2002,A1

[6]EuropeanJournalofMedicinalChemistry,2010,vol.45,p.219-226

[7]Tetrahedron,2002,vol.58,p.6117-6125

[8]Patent:WO2009/61879,2009,A1.Locationinpatent:Page/Pagecolumn129

[9]JournalofMedicinalChemistry,2016,vol.59,p.6045-6058

[10]OrganicLetters,2019,vol.21,p.8473-8478

[11]Patent:US2016/102045,2016,A1.Locationinpatent:Paragraph0339-0346

[12]Patent:KR2015/133268,2015,A.Locationinpatent:Paragraph0561;0563;0575;0586

[13]JournaloftheChemicalSociety.Chemicalcommunications,1993,p.874-875

[14]TetrahedronLetters,2000,vol.41,p.7115-7119

[15]Tetrahedron,2000,vol.56,p.9421-9429

[16]OrganicLetters,2005,vol.7,p.4765-4767

[17]BioorganicandMedicinalChemistryLetters,2008,vol.18,p.5860-5863

[18]TetrahedronLetters,2010,vol.51,p.2493-2496

[19]EuropeanJournalofOrganicChemistry,2012,p.334-344

[20]JournaloftheAmericanChemicalSociety,2014,vol.136,p.12469-12478

[21]OrganicLetters,2017,vol.19,p.1922-1925

[22]JournaloftheAmericanChemicalSociety,2017,vol.139,p.15576-15579

[23]Patent:US2018/105504,2018,A1.Locationinpatent:Paragraph0386;0387;0388

[24]Patent:WO2018/9417,2018,A1.Locationinpatent:Paragraph0369

[25]Patent:US2019/263786,2019,A1.Locationinpatent:Paragraph0210

[26]JournalofMedicinalChemistry,2020,vol.63,p.4022-4046

[1]Shah;Schafer;Recchia;Polach;LeMaster[TetrahedronLetters,1994,vol.35,#1,p.29-32]

[2]Chenault,H.Keith;Dahmer,Juergen;Whitesides,GeorgeM.[JournaloftheAmericanChemicalSociety,1989,vol.111,#16,p.6354-6364]

[3]Black;Wright[JournalofBiologicalChemistry,1955,vol.213,p.39,40]

[1]JournaloftheAmericanChemicalSociety,1987,vol.109,p.4649-4659

[1]Broxterman,QuirinusB.;Kaptein,Bernard;Kamphuis,Johan;Schoemaker,HansE.[JournalofOrganicChemistry,1992,vol.57,#23,p.6286-6294]

Literature

Title: Sustained ER Ca2+ depletion suppresses protein synthesis and induces activation-enhanced cell death in mast cells.

Journal: The Journal of biological chemistry 20020419

Title: The effect of DL-allylglycine on polyamine and GABA metabolism in mouse brain.

Journal: Journal of neurochemistry 19790501

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:16338-48-0 Molecular Formula|16338-48-0 MDL|16338-48-0 SMILES|16338-48-0 L-Allylglycine |Organic_Building_Blocks